United States
Germany
Japan
United Kingdom
China
B3GNT2 mouse monoclonal antibody, clone OTI3A9 (formerly 3A9)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
Antibodies
CD163 mouse monoclonal antibody, clone OTI3B4 (formerly 3B4)
| Applications | IF, IHC, LMNX, WB |
| Reactivities | Human |
LGR5 mouse monoclonal antibody,clone UMAB210
| Applications | 10k-ChIP, FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
Anti-HP mouse monoclonal antibody, clone OTI4H5 (formerly 4H5)
| Applications | FC, IF, WB |
| Reactivities | Human |
CD163 mouse monoclonal antibody, clone OTI2B12 (formerly 2B12)
| Applications | IF, IHC, LMNX, WB |
| Reactivities | Human |
MUC1 (EMA) mouse monoclonal antibody, clone OTI3A7 (formerly 3A7)
| Applications | IF, IHC, WB |
| Reactivities | Human |
CD163 mouse monoclonal antibody, clone OTI2F8 (formerly 2F8)
| Applications | IF, IHC, WB |
| Reactivities | Human |
TA506388 is a possible alternative to AM21062PU-N.
CD23 (FCER2) mouse monoclonal antibody,clone UMAB101
| Applications | IF, IHC, WB |
| Reactivities | Human |
TNF mouse monoclonal antibody, clone OTI1C1 (formerly 1C1)
| Applications | FC, IF, WB |
| Reactivities | Human |
CD44 mouse monoclonal antibody, clone OTI1G1 (formerly 1G1)
| Applications | IF, IHC, WB |
| Reactivities | Human |
Anti-MCL1 mouse monoclonal antibody, clone OTI10D10 (formerly 10D10)
| Applications | FC, IF, WB |
| Reactivities | Human |
CD19 mouse monoclonal antibody, clone OTI2F6 (formerly 2F6)
| Applications | FC, IF, WB |
| Reactivities | Human |
CD34 mouse monoclonal antibody, clone OTI51A1 (formerly 51A1)
| Applications | FC, IF |
| Reactivities | Human |
TMEM80 mouse monoclonal antibody, clone OTI2B7 (formerly 2B7)
| Applications | FC, IF, WB |
| Reactivities | Human |
活动过滤器
优化搜索结果
Category
Target Symbol
Reactivities
Antibody Hosts
Knockout (KO) Validation
Conjugates
Clonalities
Brands
Pathways
- Cell adhesion molecules (CAMs) (12)
- Hematopoietic cell lineage (9)
- Allograft rejection (5)
- Graft-versus-host disease (5)
- Systemic lupus erythematosus (5)
- Toll-like receptor signaling pathway (5)
- Type I diabetes mellitus (5)
- T cell receptor signaling pathway (4)
- Autoimmune thyroid disease (3)
- Viral myocarditis (3)
- Adherens junction (2)
- Adipocytokine signaling pathway (2)
- Alzheimer's disease (2)
- Amyotrophic lateral sclerosis (ALS) (2)
- Apoptosis (2)
- Asthma (2)
- B cell receptor signaling pathway (2)
- Bladder cancer (2)
- Calcium signaling pathway (2)
- Cytokine-cytokine receptor interaction (2)
- Dilated cardiomyopathy (2)
- Endometrial cancer (2)
- ErbB signaling pathway (2)
- Fc epsilon RI signaling pathway (2)
- Focal adhesion (2)
- Glycosphingolipid biosynthesis - lacto and neolacto series (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- Keratan sulfate biosynthesis (2)
- MAPK signaling pathway (2)
- Metabolic pathways (2)
- NOD-like receptor signaling pathway (2)
- Natural killer cell mediated cytotoxicity (2)
- Non-small cell lung cancer (2)
- Pancreatic cancer (2)
- Pathways in cancer (2)
- Primary immunodeficiency (2)
- Prostate cancer (2)
- RIG-I-like receptor signaling pathway (2)
- TGF-beta signaling pathway (2)
- Type II diabetes mellitus (2)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (1)
- ECM-receptor interaction (1)
- Leukocyte transendothelial migration (1)
